Select Bibliography

Filter by any of these (after searching):

Jatoi, A.

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 8 items

Using the Skindex-16 and CTCAE to assess rash symptoms: Results of a pooled-analysis (N0993).

Atherton, P. , Burger, K. , Loprinzi, C. , Miller, R. , Jatoi, A. ... - ASCO - J Clin Oncol - 2010

Abstract - Primary - Primary - Symptom Inter - NCCTG-N0993

Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511)

Freedman, Rachel A. , Seisler, D. K. , Foster, J. C. , Sloan, J. A. ... - - Breast Cancer Res Treat - 2017

Manuscript - Primary - Primary - Older Adult - A151511 , CALGB-40101 , CALGB-49907 , CALGB-9344 , CALGB-9741

Elderly patients with metastatic esophageal/gastric cancer: a pooled analysis of age-based outcomes from 8 consecutive North Central Cancer Treatment Group (NCCTG) therapeutic trials

Jatoi, A. , Foster, N. R. , Egner, J. , Burch, P. , Stella, P. J. ... - ASCO - J Clin Oncol - 2008

Abstract - Primary - Primary - GI - N064C

A phase II study of cetuximab and radiation in elderly and/or poor performance status patients with locally advanced non-small-cell lung cancer (N0422)

Jatoi, A. , Schild, S. E. , Foster, N. , Henning, G. T. ... - - Ann Oncol - 2010

Manuscript - Primary - Primary - Respiratory - NCCTG-N0422

Effect of renal function (RF) on outcomes in the adjuvant treatment of older women with breast cancer (>65 years): CALGB/CTSU 49907 (CC) ancillary data study

Lichtman, S. M. , Cirrincione, C. , Hurria, A. , Jatoi, A. ... - ASCO - J Clin Oncol - 2013

Abstract - Secondary - Primary - Older Adult - A171201 , CALGB-49907

Impact of the Algorithm for Declaring Exact Progression Data on Progression-Free Survival Estimates in Advanced Lung Cancer

Mandrekar, S. , Hillman, S. , Jatoi, A. , Jett, J. , Schild, S. ... - ASCO - J Clin Oncol - 2010

Abstract - Secondary - Primary - Respiratory - N0424

Pharmacogenetic dosing by UGT1A1 genotype as first-line therapy for advanced small-bowel adenocarcinoma: A North Central Cancer Treatment Group (NCCTG) trial

Mcwilliams, R. R. , Mahoney, M. R. , Marchello, B. T. , Jatoi, A. ... - ASCO - J Clin Oncol - 2012

Abstract - Primary - Primary - GI - N0543

The value of combined modality therapy in elderly patients with stage III non-small cell lung cancer (NSCLC)

Schild, S. , Mandrekar, S. , Jatoi, A. , Mcginnis, W. , Stella, P. ... - - J Clin Oncol - 2007

Abstract - Secondary-not-in-original - Comprehensive - Respiratory - NCCTG-94-24-52 , NCCTG-90-24-51